Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
- Name
- Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
- Accession Number
- DBCAT002376
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Emtricitabine A nucleoside reverse transcriptase inhibitor used for the treatment and prophylaxis of HIV. Didanosine A reverse transcriptase inhibitor used to treat HIV. Abacavir An antiviral nucleoside reverse transcriptase inhibitor used in combination with other antiretrovirals for the treatment of HIV. Lamivudine A reverse transcriptase inhibitor used to treat HIV and hepatitis B infections. Entecavir A nucleoside analogue used in the treatment of chronic hepatitis B for patients with active viral replication, histological evidence of active disease, or persistent elevations in liver transaminases. Adefovir dipivoxil A nucleotide analog used to treat chronic hepatitis B. Zalcitabine A dideoxynucleoside used to treat HIV. Telbivudine A thymidine nucleoside analog used for the treatment of chronic hepatitis B with clinical evidence of viral replication or persistent elevations in serum aminotransferases (ALT or AST). Clevudine Investigated for use/treatment in hepatitis (viral, B). Tenofovir disoproxil A nucleotide analog reverse transcriptase inhibitor used in the treatment of Hepatitis B infection and used in the management of HIV-1 infection. Zidovudine A dideoxynucleoside used in the treatment of HIV infection. Stavudine A dideoxynucleoside used in the treatment of HIV infection. Tenofovir alafenamide A nucleoside analog reverse transcriptase inhibitor used for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease. - Drugs & Drug Targets